Home
  • Faq
  • Release-Notes
    • Release 74.3
    • Release 74.2
    • Release 74.1
    • Release 74
    • Release 73.2
    • Release 73.1
    • Release 73
    • Release 72
    • Release 71
    • Release 70
    • Release 69
    • Release 68
    • Release 67
    • Release 66
    • Release 65
    • Release 64
    • Release 63.2
    • Release 63.1
    • Release 63
    • Release 62
    • Release 61
    • Release 60
    • Release 59
    • Release 58
    • Release 57.1
    • Release 57
    • Release 56
    • Release 55
    • Release 54
    • Release 53
    • Release 52
    • Release 51
    • Release 50
    • Release 49
    • Release 48
    • Release 47
    • Release 46
    • Release 45
    • Release 44
    • Release 43
    • Release 42
    • Release 41
    • Release 40
    • Release 39
    • Release 38
    • Release 37
    • Release 36
    • Release 35
    • Release 34
    • Release 33.1
    • Release 33
    • Release 32
    • Release 31
    • Release 30
    • Release 29
    • Release 28
    • Release 27
    • Release 26
    • Release 25
    • Release 24
    • Release 23
    • Release 22
    • Release 21
    • Release 20
    • Release 19
    • Release 18
    • Release 17
    • Release 16
    • Release 15
    • Release 14
    • Release 13
    • Release 12
    • Release 11
    • Release 10
    • Release 9
    • Release 8
    • Release 7

Release 57.1

Wednesday 28th of February 2024

New Features & Improvements

  • Supporting the switch over from EpiSurv to NDMS for measles and Covid
    • Any Measles or COVID-19 case already in EpiSurv before the go-live date of Tuesday 27th 8:00 PM should continue to be managed in EpiSurv.
    • Any Measles or COVID-19 case notified and created after the cut-off date of Tuesday 27th 8:00 PM should be managed in NDMS and will not be editable in EpiSurv.
    • The process for managing cases of diseases other than Measles and COVID-19 in EpiSurv remains unchanged.

Updated on 28 Feb 2024

Release 58 Release 57

The PHF Science Surveillance Documents are copyright © PHF Science 2025.